Redmile Group, LLC

Shattuck Labs, Inc. · Director, 10% Owner

Redmile Group, LLC is listed in public filings as director, 10 percent owner:. This Redmile Group, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Shattuck Labs, Inc. (STTK), IGM Biosciences, Inc. (IGMS), FATE THERAPEUTICS INC (FATE), Augmedix, Inc. (AUGX), and ADC Therapeutics S.A. (ADCT). Investors use Redmile Group, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
ADC Therapeutics S.A.ADCT$8.3M2.5M sharesSellApr 2, 2026$3.28--
ADC Therapeutics S.A.ADCT$8.6M2.6M sharesSellApr 2, 2026$3.28--